A prognostic signature, consisting of five genes (ACADVL, ACAT1, ACSL3, ADH4 and ECI1), was established based on 42 FAM genes, which showed good performance for the prognosis of HBV-associated HCC both in the TCGA cohort and the validation cohort. The gene discussed is ADH4; the disease is hepatocellular carcinoma.